CryoPort Debt to Equity Ratio 2012-2025 | CYRX

Current and historical debt to equity ratio values for CryoPort (CYRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CryoPort debt/equity for the three months ending September 30, 2025 was 0.40.
CryoPort Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-09-30 $0.26B $0.51B 0.51
2025-06-30 $0.26B $0.52B 0.50
2025-03-31 $0.30B $0.40B 0.76
2024-12-31 $0.30B $0.40B 0.75
2024-09-30 $0.28B $0.42B 0.68
2024-06-30 $0.45B $0.40B 1.13
2024-03-31 $0.47B $0.47B 1.00
2023-12-31 $0.47B $0.49B 0.96
2023-09-30 $0.46B $0.54B 0.86
2023-06-30 $0.49B $0.54B 0.89
2023-03-31 $0.49B $0.56B 0.87
2022-12-31 $0.48B $0.56B 0.87
2022-09-30 $0.48B $0.56B 0.86
2022-06-30 $0.48B $0.57B 0.84
2022-03-31 $0.47B $0.61B 0.77
2021-12-31 $0.47B $0.64B 0.73
2021-09-30 $0.18B $0.65B 0.27
2021-06-30 $0.18B $0.65B 0.27
2021-03-31 $0.17B $0.65B 0.27
2020-12-31 $0.17B $0.38B 0.44
2020-09-30 $0.13B $0.12B 1.10
2020-06-30 $0.13B $0.13B 1.00
2020-03-31 $0.01B $0.13B 0.10
2019-12-31 $0.01B $0.13B 0.08
2019-09-30 $0.03B $0.11B 0.22
2019-06-30 $0.02B $0.11B 0.22
2019-03-31 $0.02B $0.04B 0.54
2018-12-31 $0.02B $0.04B 0.47
2018-09-30 $0.00B $0.03B 0.10
2018-06-30 $0.00B $0.02B 0.14
2018-03-31 $0.00B $0.02B 0.12
2017-12-31 $0.00B $0.02B 0.13
2017-09-30 $0.00B $0.02B 0.11
2017-06-30 $0.00B $0.02B 0.14
2017-03-31 $0.00B $0.02B 0.18
2016-12-31 $0.00B $0.01B 0.43
2016-09-30 $0.00B $0.00B 0.62
2016-06-30 $0.00B $0.01B 0.51
2016-03-31 $0.00B $0.00B 0.88
2015-12-31 $0.00B $0.01B 0.50
2015-09-30 $0.00B $0.01B 0.33
2015-06-30 $0.00B $0.00B 0.96
2015-03-31 $0.00B $0.00B -7.26
2014-12-31 $0.00B $0.00B -2.67
2014-09-30 $0.00B $0.00B -1.88
2014-06-30 $0.00B $0.00B -2.25
2014-03-31 $0.00B $0.00B -1.74
2013-12-31 $0.00B $0.00B -2.18
2013-09-30 $0.00B $0.00B -4.04
2013-06-30 $0.01B $0.00B -1.55
2013-03-31 $0.00B $0.00B -1.85
2012-12-31 $0.00B $0.00B -4.15
2012-09-30 $0.00B $0.00B 2.66
2012-06-30 $0.00B $0.00B 0.87
2012-03-31 $0.00B $0.00B 0.67
2011-12-31 $0.00B $0.00B 5.80
2011-09-30 $0.00B $0.00B 1.57
2011-06-30 $0.01B $0.00B 1.13
2011-03-31 $0.01B $0.01B 0.86
2010-12-31 $0.01B $0.00B -4.62
2010-09-30 $0.01B $0.00B -35.95
2010-06-30 $0.01B $0.00B -2.65
2010-03-31 $0.01B $0.00B -6.22
2009-12-31 $0.02B $-0.02B -1.10
2009-09-30 $0.03B $-0.02B -1.10
2009-06-30 $0.02B $-0.02B -1.11
2009-03-31 $0.01B $-0.01B -1.33
2008-12-31 $0.01B $0.00B -1.60
2008-09-30 $0.01B $0.00B -1.93
2008-06-30 $0.01B $0.00B -3.29
2008-03-31 $0.00B $0.00B -17305.50
2007-12-31 $0.00B $0.00B 3.41
2007-09-30 $0.00B $0.00B -1.29
2007-06-30 $0.00B $0.00B -1.41
2007-03-31 $0.00B 0.00
2006-12-31 $0.00B $0.00B -1.10
2006-09-30 $0.00B $0.00B -1.10
2006-06-30 $0.00B $0.00B -1.11
2006-03-31 $0.00B 0.00
2005-12-31 $0.00B $0.00B -1.20
2005-09-30 $0.00B $0.00B -1.36
2005-06-30 $0.00B 0.00
2004-12-31 $0.00B 0.00
2004-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.418B $0.228B
CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150? Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $150.156B 27.25
HCA Healthcare (HCA) United States $120.821B 19.12
CVS Health (CVS) United States $99.843B 11.63
Elevance Health (ELV) United States $76.540B 11.49
Cencora (COR) United States $70.193B 22.08
Natera (NTRA) United States $28.526B 0.00
Labcorp Holdings (LH) United States $23.430B 17.86
DiDi Global (DIDIY) China $21.650B 20.00
Viatris (VTRS) United States $18.163B 6.77
EUROFINS SCIENT (ERFSF) Luxembourg $15.306B 0.00
BioMerieux (BMXMF) France $13.324B 0.00
Solventum (SOLV) United States $13.104B 12.72
Medpace Holdings (MEDP) United States $12.148B 27.98
Revvity (RVTY) United States $10.887B 18.94
CochLear (CHEOY) Australia $9.243B 0.00
Charles River Laboratories (CRL) United States $7.941B 15.29
ICON (ICLR) Ireland $7.510B 7.45
Sonic Healthcare (SKHHY) Australia $7.449B 0.00
BrightSpring Health Services (BTSG) United States $7.008B 41.78
HealthEquity (HQY) United States $6.312B 23.60
Avantor (AVTR) United States $6.275B 10.11
Bausch + Lomb (BLCO) Canada $6.034B 39.60
PACS (PACS) United States $5.922B 36.01
Caris Life Sciences,�Inc (CAI) United States $5.818B 0.00
Sotera Health (SHC) United States $4.864B 23.45
Alignment Healthcare (ALHC) United States $4.040B 0.00
Amplifon S.p.A (AMFPF) Italy $3.532B 20.61
Concentras Parent (CON) United States $3.017B 18.83
GeneDx Holdings (WGS) United States $2.606B 45.76
Establishment Labs Holdings (ESTA) United States $2.168B 0.00
Surgery Partners (SGRY) United States $2.000B 25.77
Organon (OGN) United States $1.921B 2.15
Pediatrix Medical (MD) United States $1.848B 11.04
Progyny (PGNY) United States $1.784B 35.07
Ardent Health (ARDT) United States $1.375B 4.49
InnovAge Holding (INNV) United States $1.134B 167.20
CareDx (CDNA) United States $1.010B 16.50
Teladoc Health (TDOC) United States $0.825B 0.00
GoodRx Holdings (GDRX) United States $0.740B 12.11
Nutex Health (NUTX) United States $0.705B 5.39
Omada Health (OMDA) United States $0.655B 0.00
Sonida Senior Living (SNDA) United States $0.641B 0.00
Embecta (EMBC) United States $0.602B 3.36
Enhabit (EHAB) United States $0.565B 25.36
COMPASS Pathways (CMPS) United Kingdom $0.558B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
SBC Medicals (SBC) United States $0.478B 8.79
Strata Critical Medical (SRTA) United States $0.396B 0.00
QDM (QDMI) Hong Kong, SAR China $0.391B 82.38
Auna S.A (AUNA) Luxembourg $0.367B 5.90
So-Young (SY) China $0.328B 0.00
Shoulder Innovations (SI) United States $0.269B 0.00
Oncology Institute (TOI) United States $0.247B 0.00
Agilon Health (AGL) United States $0.150B 0.00
LifeMD (LFMD) United States $0.134B 0.00
Beauty Health (SKIN) United States $0.133B 0.00
Ascend Wellness Holdings (AAWH) United States $0.109B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
Biodesix (BDSX) United States $0.091B 0.00
Park Dental Partners (PARK) United States $0.078B 0.00
DocGo (DCGO) United States $0.073B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.041B 0.00
IceCure Medical (ICCM) Israel $0.039B 0.00
Pomdoctor - (POM) China $0.026B 0.00
Synergy CHC (SNYR) United States $0.018B 5.62
OSR Holdings (OSRH) United States $0.013B 0.00
Basel Medical Group (BMGL) Singapore $0.012B 0.00
Lifeward (LFWD) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
XWELL (XWEL) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00